Related Articles
Early sorafenib induction after transarterial chemoembolization for unresectable hepatocellular carcinoma: Can sorafenib after TACE improve loco‑regional control?
High cholinesterase predicts tolerance to sorafenib treatment and improved prognosis in patients with transarterial chemoembolization refractory intermediate stage hepatocellular carcinoma
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study
Repeated transarterial chemoembolization with epirubicin‑loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma